Delivery Order SPE2DB25D3402-SPE2DB26FUFXC
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on June 18, 2025, for the supply of Viberzi 75 mg tablets (60-count units) with a ceiling value of $1,707.63. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is scheduled for completion by June 20, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,707.63 for 60 tablets of Viberzi 100 mg, a pharmaceutical product used in the treatment of irritable bowel syndrome. This non-set-aside, firm fixed-price contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a $1,707.60 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Viberzi 75 mg tablets (60-count package). This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive $999,999,999.00 global pharmaceutical support vehicle valued through December 2026. The product will be delivered to the company's...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 27, 2025, for the supply of Viberzi 100 mg tablets (60-count) with a contract value of $1,480.32. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of May 28, 2025. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award represents a continuation of AmerisourceBergen's substantial role as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,711.03 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg, a pharmaceutical product for gastrointestinal treatment. This competitively awarded, non-set-aside contract employs firm fixed pricing and carries an ultimate completion date of May 19, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $1,716.59. The award, issued on June 9, 2025, with an ultimate completion date of June 10, 2025, represents a non-set-aside competitive procurement. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $2,136.20 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Viberzi 75 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,707.63 for 60 tablets of Viberzi 100 mg, with a completion date of July 28, 2025. This competitively awarded, firm fixed-price contract represents a pediatric order from the pharmaceutical distributor's extensive portfolio of federal medical supply contracts. The contract was executed on July 25, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,881.75 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg on August 14, 2025, with completion scheduled for August 15, 2025. This competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The pharmaceutical will be delivered to...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a firm fixed price delivery order valued at one thousand six hundred fifty dollars and fifty-seven cents ($1,650.57) to supply one hundred (100) tablets of Viberzi, a medication used to treat irritable bowel syndrome with diarrhea, to the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) organization. Performance will take place in Conshohocken, Pennsylvania under a one-day period from...
- SPE2DB25D3402Indefinite Delivery Contract
- SPE2DB25D3402-SPE2DB26FUFXCDelivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 60 tablets of Viberzi 75 mg, a prescription medication used to treat irritable bowel syndrome. The order, valued at $1,707.60 with a firm fixed price, was competitively awarded without set-aside designation and is scheduled for completion by November 6, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, medical devices, and specialized healthcare commodities to military healthcare systems worldwide. The DLA Troop Support Medical supply chain relies on such contracts to ensure consistent pharmaceutical availability across Defense Health Agency, U.S. Coast Guard, and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/5/25 |